
Illumina Upgrades Genomic AI to Decode Rare Disease Variants
By identifying 17% more disease-relevant genetic variants than its predecessor, Illumina’s new SpliceAI2 model aims to shrink the portion of the human genome that remains uninterpretable. The tool, released October 8, addresses the persistent challenge of predicting how specific mutations disrupt protein production and trigger rare conditions.




















/https://i.s3.glbimg.com/v1/AUTH_f035dd6fd91c438fa04ab718d608bbaa/internal_photos/bs/2025/Y/Z/k0PDQKSOGxoW9aQcYxAA/gettyimages-1354411935.jpg)



